顺铂与卡铂用于转移性非小细胞肺癌患者——一场旧有的竞争再度展开。 - Suppr

Suppr

超能文献

Cisplatin versus carboplatin for patients with metastatic non-small-cell lung cancer--an old rivalry renewed.

作者信息

Azzoli Christopher G, Kris Mark G, Pfister David G

出版信息

J Natl Cancer Inst. 2007 Jun 6;99(11):828-9. doi: 10.1093/jnci/djk222.

DOI:10.1093/jnci/djk222

PMID:17551137

Abstract

摘要

相似文献

Cisplatin versus carboplatin for patients with metastatic non-small-cell lung cancer--an old rivalry renewed.

J Natl Cancer Inst. 2007 Jun 6;99(11):828-9. doi: 10.1093/jnci/djk222.

Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer.

J Clin Oncol. 2004 Oct 1;22(19):3852-9. doi: 10.1200/JCO.2004.02.109. Epub 2004 Aug 23.

Platinums in lung cancer: sufficient or necessary?

J Clin Oncol. 2005 May 1;23(13):2882-3. doi: 10.1200/JCO.2005.11.930. Epub 2005 Feb 22.

Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: does cisplatin versus carboplatin make a difference?

J Clin Oncol. 2005 Sep 1;23(25):6276-7; author reply 6277-8. doi: 10.1200/JCO.2005.02.0156.

[A meta-analysis of the curative effects of carboplatin-based and cisplatin-based chemotherapeutic regimens on advance non-small cell lung cancer].

Zhonghua Yi Xue Za Zhi. 2006 Oct 10;86(37):2615-20.

Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature.

Lung Cancer. 2009 May;64(2):131-9. doi: 10.1016/j.lungcan.2008.08.006. Epub 2008 Sep 19.

[Chemotherapy for metastased non-small cell lung cancer].

Ned Tijdschr Geneeskd. 2004 Aug 21;148(34):1670-4.

[Clinical use of platinum compounds and fluorinated pyrimidines for lung cancer].

Gan To Kagaku Ryoho. 1996 Nov;23(13):1747-56.

Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.

J Natl Cancer Inst. 2007 Aug 1;99(15):1210; author reply 1210-1. doi: 10.1093/jnci/djm051. Epub 2007 Jul 24.

Aggressive treatment for the fit elderly with non-small-cell lung cancer? Yes!

J Clin Oncol. 2003 Sep 1;21(17):3186-8. doi: 10.1200/JCO.2003.04.002. Epub 2003 Jul 21.

引用本文的文献

Folic Acid Antimetabolites (Antifolates): A Brief Review on Synthetic Strategies and Application Opportunities.

Molecules. 2022 Sep 22;27(19):6229. doi: 10.3390/molecules27196229.

Efficacy and Safety of Neoadjuvant Targeted Therapy vs. Neoadjuvant Chemotherapy for Stage IIIA EGFR-Mutant Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Front Surg. 2021 Aug 19;8:715318. doi: 10.3389/fsurg.2021.715318. eCollection 2021.

Sequential Treatment with an Immune Checkpoint Inhibitor Followed by a Small-Molecule Targeted Agent Increases Drug-Induced Pneumonitis.

Cancer Res Treat. 2021 Jan;53(1):77-86. doi: 10.4143/crt.2020.543. Epub 2020 Aug 6.

First-line treatment of nonsquamous NSCLC using gemcitabine: a retrospective study of real-life practice.

Lung Cancer Manag. 2016 Nov;5(3):123-130. doi: 10.2217/lmt-2016-0011. Epub 2016 Nov 3.

Temporal patterns of care and outcomes of non-small cell lung cancer patients in the United States diagnosed in 1996, 2005, and 2010.

Lung Cancer. 2017 Jan;103:66-74. doi: 10.1016/j.lungcan.2016.11.020. Epub 2016 Nov 29.

Validity of new methods to evaluate renal function in cancer patients treated with cisplatin.

Cancer Chemother Pharmacol. 2016 Feb;77(2):281-8. doi: 10.1007/s00280-016-2966-1. Epub 2016 Jan 20.

Direct Activation of Bax Protein for Cancer Therapy.

Med Res Rev. 2016 Mar;36(2):313-41. doi: 10.1002/med.21379. Epub 2015 Sep 23.

Nedaplatin or oxaliplatin combined with paclitaxel and docetaxel as first-line treatment for patients with advanced non-small cell lung cancer.

Med Sci Monit. 2014 Dec 30;20:2830-6. doi: 10.12659/MSM.891318.

Activation of the proapoptotic Bcl-2 protein Bax by a small molecule induces tumor cell apoptosis.

Mol Cell Biol. 2014 Apr;34(7):1198-207. doi: 10.1128/MCB.00996-13. Epub 2014 Jan 13.

Impact of renal function on treatment options and outcomes in advanced non-small cell lung cancer.

Lung Cancer. 2013 Jun;80(3):326-32. doi: 10.1016/j.lungcan.2013.02.011. Epub 2013 Mar 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Cisplatin versus carboplatin for patients with metastatic non-small-cell lung cancer--an old rivalry renewed.

作者信息

Azzoli Christopher G, Kris Mark G, Pfister David G

出版信息

J Natl Cancer Inst. 2007 Jun 6;99(11):828-9. doi: 10.1093/jnci/djk222.

DOI:10.1093/jnci/djk222

PMID:17551137

Abstract

摘要

相似文献

Cisplatin versus carboplatin for patients with metastatic non-small-cell lung cancer--an old rivalry renewed.

J Natl Cancer Inst. 2007 Jun 6;99(11):828-9. doi: 10.1093/jnci/djk222.

Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer.

J Clin Oncol. 2004 Oct 1;22(19):3852-9. doi: 10.1200/JCO.2004.02.109. Epub 2004 Aug 23.

Platinums in lung cancer: sufficient or necessary?

J Clin Oncol. 2005 May 1;23(13):2882-3. doi: 10.1200/JCO.2005.11.930. Epub 2005 Feb 22.

Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: does cisplatin versus carboplatin make a difference?

J Clin Oncol. 2005 Sep 1;23(25):6276-7; author reply 6277-8. doi: 10.1200/JCO.2005.02.0156.

[A meta-analysis of the curative effects of carboplatin-based and cisplatin-based chemotherapeutic regimens on advance non-small cell lung cancer].

Zhonghua Yi Xue Za Zhi. 2006 Oct 10;86(37):2615-20.

Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature.

Lung Cancer. 2009 May;64(2):131-9. doi: 10.1016/j.lungcan.2008.08.006. Epub 2008 Sep 19.

[Chemotherapy for metastased non-small cell lung cancer].

Ned Tijdschr Geneeskd. 2004 Aug 21;148(34):1670-4.

[Clinical use of platinum compounds and fluorinated pyrimidines for lung cancer].

Gan To Kagaku Ryoho. 1996 Nov;23(13):1747-56.

Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.

J Natl Cancer Inst. 2007 Aug 1;99(15):1210; author reply 1210-1. doi: 10.1093/jnci/djm051. Epub 2007 Jul 24.

Aggressive treatment for the fit elderly with non-small-cell lung cancer? Yes!

J Clin Oncol. 2003 Sep 1;21(17):3186-8. doi: 10.1200/JCO.2003.04.002. Epub 2003 Jul 21.

引用本文的文献

Folic Acid Antimetabolites (Antifolates): A Brief Review on Synthetic Strategies and Application Opportunities.

Molecules. 2022 Sep 22;27(19):6229. doi: 10.3390/molecules27196229.

Efficacy and Safety of Neoadjuvant Targeted Therapy vs. Neoadjuvant Chemotherapy for Stage IIIA EGFR-Mutant Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Front Surg. 2021 Aug 19;8:715318. doi: 10.3389/fsurg.2021.715318. eCollection 2021.

Sequential Treatment with an Immune Checkpoint Inhibitor Followed by a Small-Molecule Targeted Agent Increases Drug-Induced Pneumonitis.

Cancer Res Treat. 2021 Jan;53(1):77-86. doi: 10.4143/crt.2020.543. Epub 2020 Aug 6.

First-line treatment of nonsquamous NSCLC using gemcitabine: a retrospective study of real-life practice.

Lung Cancer Manag. 2016 Nov;5(3):123-130. doi: 10.2217/lmt-2016-0011. Epub 2016 Nov 3.

Temporal patterns of care and outcomes of non-small cell lung cancer patients in the United States diagnosed in 1996, 2005, and 2010.

Lung Cancer. 2017 Jan;103:66-74. doi: 10.1016/j.lungcan.2016.11.020. Epub 2016 Nov 29.

Validity of new methods to evaluate renal function in cancer patients treated with cisplatin.

Cancer Chemother Pharmacol. 2016 Feb;77(2):281-8. doi: 10.1007/s00280-016-2966-1. Epub 2016 Jan 20.

Direct Activation of Bax Protein for Cancer Therapy.

Med Res Rev. 2016 Mar;36(2):313-41. doi: 10.1002/med.21379. Epub 2015 Sep 23.

Nedaplatin or oxaliplatin combined with paclitaxel and docetaxel as first-line treatment for patients with advanced non-small cell lung cancer.

Med Sci Monit. 2014 Dec 30;20:2830-6. doi: 10.12659/MSM.891318.

Activation of the proapoptotic Bcl-2 protein Bax by a small molecule induces tumor cell apoptosis.

Mol Cell Biol. 2014 Apr;34(7):1198-207. doi: 10.1128/MCB.00996-13. Epub 2014 Jan 13.

Impact of renal function on treatment options and outcomes in advanced non-small cell lung cancer.

Lung Cancer. 2013 Jun;80(3):326-32. doi: 10.1016/j.lungcan.2013.02.011. Epub 2013 Mar 15.